 | • レポートコード：MRC2-11QY04786 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は全身性乾癬治療薬のグローバル市場について調査・分析したレポートです。種類別（生物製剤、小分子）市場規模、用途別（軽度乾癬、中度乾癬、重度乾癬）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別全身性乾癬治療薬の競争状況、市場シェア ・世界の全身性乾癬治療薬市場：種類別市場規模 2015年-2020年（生物製剤、小分子） ・世界の全身性乾癬治療薬市場：種類別市場規模予測 2021年-2026年（生物製剤、小分子） ・世界の全身性乾癬治療薬市場：用途別市場規模 2015年-2020年（軽度乾癬、中度乾癬、重度乾癬） ・世界の全身性乾癬治療薬市場：用途別市場規模予測 2021年-2026年（軽度乾癬、中度乾癬、重度乾癬） ・北米の全身性乾癬治療薬市場分析：米国、カナダ ・ヨーロッパの全身性乾癬治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの全身性乾癬治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の全身性乾癬治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの全身性乾癬治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、Johnson & Johnson、Celgene、Amgen、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcohol consumption, cold weather, certain medications, smoking, stress and injury to the skin such as bug bite, cut and sever sunburn. The signs and symptoms of psoriasis vary from person to person which includes dry, cracked skin that may bleed, red patches of skin covered with silvery scales, small scaling spots, itching, burning, swollen and stiff joints. Psoriasis may be classified into various types such as plaque psoriasis, scalp psoriasis, pustular psoriasis, psoriatic arthritis, guttate psoriasis, nail psoriasis, erythrodermic psoriasis and inverse psoriasis. Various treatments for psoriasis are oral medication, topical medication and biologics injections. Psoriasis can also be treating by phototherapy treatment which includes ultraviolet light therapy, laser treatment, tanning beds, psoralen +UVA and sunlight treatment. Psoriasis can occur in any part of the body and it is associated with other health conditions such as heart disease, diabetes and depression.
One trend resulting in the strong growth of this market is the advent of biologics with novel MOA and cell-based strategies. This market is expected to witness the launch of biologic agents that target the disease pathway specifically, including IL-17/IL-17R receptor inhibitors. Drugs such as brodalumab, guselkumab, and tildrakizumab are undergoing Phase III clinical trials.
Market Analysis and Insights: Global Systemic Psoriasis Therapeutics Market
The global Systemic Psoriasis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Systemic Psoriasis Therapeutics Scope and Market Size
Systemic Psoriasis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie
Johnson & Johnson
Celgene
Amgen
Pfizer
…
Market segment by Type, the product can be split into
Biologics
Small Molecules
Market segment by Application, split into
Mild Psoriasis
Moderate Psoriasis
Severe Psoriasis
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Systemic Psoriasis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biologics
1.4.3 Small Molecules
1.5 Market by Application
1.5.1 Global Systemic Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Mild Psoriasis
1.5.3 Moderate Psoriasis
1.5.4 Severe Psoriasis
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Systemic Psoriasis Therapeutics Market Perspective (2015-2026)
2.2 Global Systemic Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Systemic Psoriasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Systemic Psoriasis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Systemic Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Systemic Psoriasis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Systemic Psoriasis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Systemic Psoriasis Therapeutics Players by Market Size
3.1.1 Global Top Systemic Psoriasis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Systemic Psoriasis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Systemic Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Systemic Psoriasis Therapeutics Market Concentration Ratio
3.2.1 Global Systemic Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Systemic Psoriasis Therapeutics Revenue in 2019
3.3 Systemic Psoriasis Therapeutics Key Players Head office and Area Served
3.4 Key Players Systemic Psoriasis Therapeutics Product Solution and Service
3.5 Date of Enter into Systemic Psoriasis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Systemic Psoriasis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
5.2 Global Systemic Psoriasis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Systemic Psoriasis Therapeutics Market Size (2015-2020)
6.2 Systemic Psoriasis Therapeutics Key Players in North America (2019-2020)
6.3 North America Systemic Psoriasis Therapeutics Market Size by Type (2015-2020)
6.4 North America Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Systemic Psoriasis Therapeutics Market Size (2015-2020)
7.2 Systemic Psoriasis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Systemic Psoriasis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Systemic Psoriasis Therapeutics Market Size (2015-2020)
8.2 Systemic Psoriasis Therapeutics Key Players in China (2019-2020)
8.3 China Systemic Psoriasis Therapeutics Market Size by Type (2015-2020)
8.4 China Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Systemic Psoriasis Therapeutics Market Size (2015-2020)
9.2 Systemic Psoriasis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Systemic Psoriasis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Systemic Psoriasis Therapeutics Market Size (2015-2020)
10.2 Systemic Psoriasis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Systemic Psoriasis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Systemic Psoriasis Therapeutics Market Size (2015-2020)
11.2 Systemic Psoriasis Therapeutics Key Players in India (2019-2020)
11.3 India Systemic Psoriasis Therapeutics Market Size by Type (2015-2020)
11.4 India Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Systemic Psoriasis Therapeutics Market Size (2015-2020)
12.2 Systemic Psoriasis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Systemic Psoriasis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Systemic Psoriasis Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Systemic Psoriasis Therapeutics Introduction
13.1.4 AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Systemic Psoriasis Therapeutics Introduction
13.2.4 Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Celgene
13.3.1 Celgene Company Details
13.3.2 Celgene Business Overview
13.3.3 Celgene Systemic Psoriasis Therapeutics Introduction
13.3.4 Celgene Revenue in Systemic Psoriasis Therapeutics Business (2015-2020)
13.3.5 Celgene Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview
13.4.3 Amgen Systemic Psoriasis Therapeutics Introduction
13.4.4 Amgen Revenue in Systemic Psoriasis Therapeutics Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Systemic Psoriasis Therapeutics Introduction
13.5.4 Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2015-2020)
13.5.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Systemic Psoriasis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Systemic Psoriasis Therapeutics Revenue
Table 3. Ranking of Global Top Systemic Psoriasis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Systemic Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologics
Table 6. Key Players of Small Molecules
Table 7. Global Systemic Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Systemic Psoriasis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Systemic Psoriasis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Systemic Psoriasis Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Systemic Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Systemic Psoriasis Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Systemic Psoriasis Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Systemic Psoriasis Therapeutics Players
Table 18. Global Systemic Psoriasis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Systemic Psoriasis Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Psoriasis Therapeutics as of 2019)
Table 21. Global Systemic Psoriasis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Systemic Psoriasis Therapeutics Product Solution and Service
Table 24. Date of Enter into Systemic Psoriasis Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Systemic Psoriasis Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Systemic Psoriasis Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Systemic Psoriasis Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Systemic Psoriasis Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Systemic Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Systemic Psoriasis Therapeutics Market Share (2019-2020)
Table 34. North America Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Systemic Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 36. North America Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Systemic Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Systemic Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Systemic Psoriasis Therapeutics Market Share (2019-2020)
Table 40. Europe Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Systemic Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Systemic Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Systemic Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Systemic Psoriasis Therapeutics Market Share (2019-2020)
Table 46. China Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Systemic Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 48. China Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Systemic Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Systemic Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Systemic Psoriasis Therapeutics Market Share (2019-2020)
Table 52. Japan Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Systemic Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Systemic Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Systemic Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Systemic Psoriasis Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Systemic Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Systemic Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Systemic Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Systemic Psoriasis Therapeutics Market Share (2019-2020)
Table 64. India Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Systemic Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 66. India Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Systemic Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Systemic Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Systemic Psoriasis Therapeutics Market Share (2019-2020)
Table 70. Central & South America Systemic Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Systemic Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Systemic Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Systemic Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Product
Table 77. AbbVie Revenue in Systemic Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 78. AbbVie Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Product
Table 82. Johnson & Johnson Revenue in Systemic Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 83. Johnson & Johnson Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Product
Table 87. Celgene Revenue in Systemic Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 88. Celgene Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Product
Table 92. Amgen Revenue in Systemic Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 93. Amgen Recent Development
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Product
Table 97. Pfizer Revenue in Systemic Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 98. Pfizer Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Psoriasis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Biologics Features
Figure 3. Small Molecules Features
Figure 4. Global Systemic Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Mild Psoriasis Case Studies
Figure 6. Moderate Psoriasis Case Studies
Figure 7. Severe Psoriasis Case Studies
Figure 8. Systemic Psoriasis Therapeutics Report Years Considered
Figure 9. Global Systemic Psoriasis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Systemic Psoriasis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 11. Global Systemic Psoriasis Therapeutics Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Systemic Psoriasis Therapeutics Market Share by Players in 2019
Figure 14. Global Top Systemic Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Psoriasis Therapeutics as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Systemic Psoriasis Therapeutics Revenue in 2019
Figure 16. North America Systemic Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Systemic Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Systemic Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Systemic Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Systemic Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Systemic Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Systemic Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
慢性尋常性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type…- 尋常性乾癬治療の世界市場（～2026年） Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy. When treating plaque psoriasis, it must be remembered that topical medications and light will have difficulty penetrating through th…
- 乾癬治療薬の世界市場（～2026年） Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to…
- 全身性肥満細胞症治療の世界市場（～2026年） Market Analysis and Insights: Global Systemic Mastocytosis Treatment Market The global Systemic Mastocytosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Systemic Mastocytosis Treatment Scope and Market Si…
- 全身感染症治療の世界市場（～2026年） Systemic infection earns its name by being spread throughout the systems of the body. Systemic infections are not necessarily more severe than local infections. Market Analysis and Insights: Global Systemic Infection Treatment Market The global Systemic Infection Treatment market size is projected t…